Mirae Asset Global Etfs Holdings Ltd. Nuvectis Pharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 7,029 shares of NVCT stock, worth $42,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,029Holding current value
$42,244% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NVCT
# of Institutions
50Shares Held
3.21MCall Options Held
44.5KPut Options Held
50.1K-
Vanguard Group Inc Valley Forge, PA667KShares$4.01 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.38 Million5.37% of portfolio
-
Iridian Asset Management LLC373KShares$2.24 Million1.01% of portfolio
-
Baldwin Brothers LLC350KShares$2.11 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA285KShares$1.71 Million0.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $88M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...